HyMedPoly – Drug-Free Antibacterial Hybrid Biopolymers for Medical Applications
HyMedPoly aims to develop new therapies based on biomedical drug-free antibacterial polymers and inorganic materials for drug-free antibacterial hybrid biopolymers for infections.
Infection has become one of the toughest problems in the medical world, and as bacteria become more resistant to drugs there are fewer effective antibiotics to fight against pathogens.
Our ultimate goals are to develop a new generation of professionals who will play a pivotal role in pushing forward this challenging and knowledge-intensive field for the coming decades to benefit the European economy and will be able to bring state-of-the-art technology to industry, advance products for hospitals and personal healthcare and develop new and improved therapeutic strategies.
HyMedPoly is a four year project and has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 643050.
Go to List of project partners, please click here
Go to Approach page, please click here
Go to Projects and Research page, please click here